株式会社ＰＲＩＳＭ ＢｉｏＬａｂ
206A | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 藤沢市村岡東二丁目２６番１号
- Website:
- https://prismbiolab.com/ja/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
PRISM BioLab, a pioneering Japanese bioventure, is dedicated to transforming previously "undruggable" targets into viable therapeutic options through its innovative PepMetics® technology. This unique drug discovery platform utilizes low molecular weight compounds with distinctive frameworks that mimic α-helix and β-turn peptides, enabling precise control of protein-protein interactions. PRISM BioLab aims to address diseases that currently lack effective treatments, positioning itself at the forefront of drug discovery and development. By harnessing cutting-edge technology, the company is committed to advancing healthcare and improving patient outcomes globally.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-17 09:30 |
Inside Information Statement
臨時報告書
|
Japanese | 21.0 KB | |
| 2025-05-14 09:31 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-05-14 09:30 |
Interim Report
半期報告書－第14期(2024/10/01－2025/09/30)
|
Japanese | 224.7 KB | |
| 2024-12-27 07:34 |
Internal Control over Financial Reporting
内部統制報告書－第13期(2023/10/01－2024/09/30)
|
Japanese | 22.2 KB | |
| 2024-12-27 07:33 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-12-27 07:32 |
Annual Report
有価証券報告書－第13期(2023/10/01－2024/09/30)
|
Japanese | 3.1 MB | |
| 2024-12-27 07:31 |
Inside Information Statement
臨時報告書
|
Japanese | 22.1 KB | |
| 2024-11-14 07:32 |
Inside Information Statement
臨時報告書
|
Japanese | 20.8 KB | |
| 2024-10-16 10:12 |
Inside Information Statement
臨時報告書
|
Japanese | 20.7 KB | |
| 2024-09-10 09:09 |
Inside Information Statement
臨時報告書
|
Japanese | 19.9 KB | |
| 2024-06-24 08:00 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 2.2 MB | |
| 2024-06-14 08:00 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 2.3 MB | |
| 2024-05-27 08:00 |
Prospectus
有価証券届出書（新規公開時）
|
Japanese | 4.3 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
| Canzon Israel Ltd. | Israel | CNZN | ||
|
Carna Biosciences, Inc. | Japan | 4572 | |
|
CATALYST MEDIA GROUP PLC | United Kingdom | CMX | |
|
Celon Pharma S.A. | Poland | CLN | |
|
Chemical Works of Gedeon Richter Plc | Hungary | RICHT | |
|
Chiome Bioscience Inc. | Japan | 4583 | |
|
Chordia Therapeutics,Inc | Japan | 190A | |
|
CHUGAI PHARMACEUTICAL CO., LTD. | Japan | 4519 | |
|
CHUKYOIYAKUHIN CO.,LTD. | Japan | 4558 | |
|
COSMO Pharmaceuticals N.V. | Netherlands (Kingdom of the) | COPN |